Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...

Bernstein launched the coverage of insulin pump makers Tandem Diabetes Care (NASDAQ:TNDM) and Insulet Corporation (NASDAQ:PODD) with outperform recommendations just as the duo prepares to release ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a medical device company specializing in diabetes management products, has been making waves in the insulin pump market with its recent product launches and ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Tandem Mobi is pioneering a new category of insulin pumps, and market awareness is building as the diabetes community has increasing exposure to our new platform. Turning to our performance ...

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now discontinuing its patch pump program as part of a broader restructuring ...